Factor VIII Deficient Plasma is manufactured from normal citrated human plasma that has been depleted of Factor VIII (FVIII) by selective affinity immuno-adsorption using antibodies directed towards FVIII. Our Factor VIII Deficient Plasma is deficient in FVIII to less than 1% activity. During the depletion process vWF levels are reduced to below normal levels.

Only the highest quality citrated plasma is used as starting material and in many cases the parent plasma is available as control material. Plasma products are typically buffered with the addition of HEPES to 20 mM final concentration and are available in 1.0 mL vials to litre quantities. Our Factor VIII Deficient Plasma can be used for further manufacturing or research use only applications. It has not been validated for use in Thrombin Generation Assays.

Request Certificate of Analysis